Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer-Reference-Cited by-同舟云学术

Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer

Published:2021-01-01 Issue:1 Volume:12 Page:8419-8434
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Liu Mingzhou¹²,Li Qiaoyan¹,Zhao Ningmin¹

Affiliation:

1. Department of Pharmacy, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Zhengzhou, Henan, China

2. Tissue Engineering Laboratory, Henan Eye Institute, Henan Eye Hospital, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Zhengzhou, China

Funder

National Natural Science Foundation of China

Wu Jieping Medical Foundation

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1977768

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane

3. Chemoresistance mechanisms of breast cancer and their countermeasures

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of TNBC Cell Growth by Paroxetine: Induction of Apoptosis and Blockage of Autophagy Flux;Cancers;2024-02-22

2. Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing;Frontiers in Oncology;2022-05-18

3. Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies;Cells;2022-03-27

4. Tumor microenvironment-related multigene prognostic prediction model for breast cancer;Aging;2022-01-20

5. MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer;Computational and Structural Biotechnology Journal;2022